tiprankstipranks
Trending News
More News >

Kissei Pharmaceutical Reports Modest Profit Growth Amidst Sales Increase

Story Highlights
Kissei Pharmaceutical Reports Modest Profit Growth Amidst Sales Increase

Confident Investing Starts Here:

Kissei Pharmaceutical Co ( (JP:4547) ) has provided an announcement.

Kissei Pharmaceutical Co., Ltd. reported a 13.5% increase in net sales for the nine months ending December 31, 2024, compared to the previous year. Despite this growth, the company experienced a decline in ordinary profit by 13.1%, though profit attributable to owners rose by 6.0%. The company’s financial position remained strong with a high equity ratio of 84.4%. No revisions were made to the previously announced forecast for the fiscal year ending March 31, 2025, indicating stable expectations despite the challenges reflected in ordinary profit.

More about Kissei Pharmaceutical Co

Kissei Pharmaceutical Co., Ltd. is a company listed on the Tokyo Stock Exchange, operating within the pharmaceutical industry. It specializes in the development and distribution of pharmaceutical products, focusing on innovation and addressing unmet medical needs.

YTD Price Performance: -2.56%

Average Trading Volume: 750

Technical Sentiment Consensus Rating: Strong Sell

Current Market Cap: $1.07B

Find detailed analytics on 4547 stock on TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App